Product description

Probiotic complex targeting the metabolic syndrome composed by L. plantarum - PBS067, L. acidophilus PBS066 and L. reuteri PBS072. Their selection comes from a priori in-vitro screening on their ability in improving both lipid and carbohydrates metabolism, as well as in modulating the inflammation process.

SynBalance® MetSyn has been then clinically tested in a randomized double blind placebo controlled clinical trial, underlining a positive effect on body circumference and visceral adiposity, besides restoration of healthy lipid metabolic profile, modulation of chronic inflammation and improvement of life quality.

Read more

Specifications

Categories Probiotics
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Central/South America
Supplied from Italy
Product Applications Dietary Supplements; Food Supplements; Pharmaceutical
Product Certifications Sustainable Seafood

More products from SYNBALANCE SRL

Products from other suppliers

MetSyn

Contact information

Address

Email

Telephone

Website

View all contact information